SGPL1 and psoriasis: Nevertheless, evidence from tamoxifen-inducible Sgpl1 knock-out mice has shown Sgpl1 malfunctions boosted S1P but diminished C16 ceramide concentration within the skin and induced hyperkeratosis, which threatened Sgpl1 inhibition for psoriasis treatment (5).